Ambu A/S: Q3 pre-close brief-fil
7/8 18:18
Ambu Q3 2024/25 expects front-loaded revenue growth due to strong Q1 order-phasing in Pulmonology and Anaesthesia & Patient Monitoring. H1 organic revenue growth at 15.4%, with a 12-month rolling growth of 14.1%. Endoscopy Solutions posted 16.7% growth for H1, driven by 4 new products. Anaesthesia & Patient Monitoring saw a 13.6% growth in H1, aided […]...